The disorder, thought to affect an estimated 8-13% of women of reproductive age, can cause irregular periods, hormone imbalances and infertility
During the GLP-1 shortages in 2022, the FDA permitted compounding to bridge supply gaps, but with shortages officially resolved there has been a lot of debate over the sale of compounded alternatives
This level of service ensures that your treatment is both safe and effective, reducing the risk of complications
Reconstituted tirzepatide remains stable for approximately 28 days when stored properly in the refrigerator
I read all the reviews and was convinced to give it a shot
The assumption makes sense on the surface: both are injectable GLP-1 medications, both are delivered under the skin, so the identical technique must work equally well for both